Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
J-BAF study: Bepridil for conversion of persistent atrial fibrillation
jRCT1091220005Completed
- Sponsor
- TOA EIYO
- Start
- Feb 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in Atrial fibrillation (AFib) comparing Bepridil with Placebo (2 arms). Primary endpoint: Sinus rhythm conversion rate. Started Feb 2006; status: completed.
02
Drugs
bepridil
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on jRCT1091220005.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1091220005.